NATURAL ALTERNATIVES INTERNATIONAL INC Cost of Revenue
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) reported Cost of Revenue of $31.32 million for the 105-month period ending 2031-09-25, per its 10-Q filed 2023-05-15.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2026-05-19
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for the quarter ending 2026-03-31 was $35.10M, a 30.29% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for the quarter ending 2025-12-31 was $32.30M, a 0.32% decline year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for the quarter ending 2025-09-30 was $33.33M, a 7.91% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for the quarter ending 2025-06-30 was $30.33M, a 8.05% increase year-over-year.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for fiscal 2025 was $120.57M, a 12.76% increase from fiscal 2024.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for fiscal 2024 was $106.93M, a 21.29% decline from fiscal 2023.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for fiscal 2023 was $135.86M, a 3.28% decline from fiscal 2022.
- NATURAL ALTERNATIVES INTERNATIONAL INC cost of goods and services sold for fiscal 2022 was $140.46M, a 5.15% decline from fiscal 2021.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month | Cost of Goods and Services Sold 105 month |
|---|---|---|---|---|---|
| 2031-09-25 | $31.32M 10-Q · filed 2023-05-15 | ||||
| 2026-03-31 | $35.10M 10-Q · filed 2026-05-19 | $67.40M derived: sum of 2 quarters · filed 2026-05-19 | $100.74M 10-Q · filed 2026-05-19 | $131.07M derived: sum of 4 quarters · filed 2026-05-19 | |
| 2025-12-31 | $32.30M 10-Q · filed 2026-02-13 | $65.64M 10-Q · filed 2026-02-13 | $95.97M derived: sum of 3 quarters · filed 2026-02-13 | $122.91M derived: sum of 4 quarters · filed 2026-05-19 | |
| 2025-09-30 | $33.33M 10-Q · filed 2025-11-12 | $63.66M derived: sum of 2 quarters · filed 2025-11-12 | $90.60M derived: sum of 3 quarters · filed 2026-05-19 | $123.01M derived: sum of 4 quarters · filed 2026-05-19 | |
| 2025-06-30 | $30.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $57.27M derived: sum of 2 quarters · filed 2026-05-19 | $89.68M derived: sum of 3 quarters · filed 2026-05-19 | $120.57M 10-K · filed 2025-09-23 | |
| 2025-03-31 | $26.94M 10-Q · filed 2026-05-19 | $59.35M derived: sum of 2 quarters · filed 2026-05-19 | $90.24M 10-Q · filed 2026-05-19 | $118.31M derived: sum of 4 quarters · filed 2026-05-19 | |
| 2024-12-31 | $32.41M 10-Q · filed 2026-02-13 | $63.30M 10-Q · filed 2026-02-13 | $91.37M derived: sum of 3 quarters · filed 2026-02-13 | $114.58M derived: sum of 4 quarters · filed 2026-02-13 | |
| 2024-09-30 | $30.89M 10-Q · filed 2025-11-12 | $58.96M derived: sum of 2 quarters · filed 2025-11-12 | $82.17M derived: sum of 3 quarters · filed 2025-11-12 | $106.99M derived: sum of 4 quarters · filed 2025-11-12 | |
| 2024-06-30 | $28.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-23 | $51.28M derived: sum of 2 quarters · filed 2025-09-23 | $76.10M derived: sum of 3 quarters · filed 2025-09-23 | $106.93M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $23.21M 10-Q · filed 2025-05-14 | $48.03M derived: sum of 2 quarters · filed 2025-05-14 | $78.86M 10-Q · filed 2025-05-14 | $109.56M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $24.82M 10-Q · filed 2025-02-14 | $55.65M 10-Q · filed 2025-02-14 | $86.34M derived: sum of 3 quarters · filed 2025-02-14 | $117.67M derived: sum of 4 quarters · filed 2025-02-14 | |
| 2023-09-30 | $30.83M 10-Q · filed 2024-11-13 | $61.53M derived: sum of 2 quarters · filed 2024-11-13 | $92.85M derived: sum of 3 quarters · filed 2024-11-13 | $128.93M derived: sum of 4 quarters · filed 2024-11-13 | |
| 2023-06-30 | $30.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-27 | $62.02M derived: sum of 2 quarters · filed 2024-09-27 | $98.10M derived: sum of 3 quarters · filed 2024-09-27 | $135.86M 10-K · filed 2024-09-27 | |
| 2023-03-31 | $31.32M 10-Q · filed 2024-05-14 | $67.40M derived: sum of 2 quarters · filed 2024-05-14 | $105.16M 10-Q · filed 2023-05-15 | $149.40M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $36.08M 10-Q · filed 2024-02-13 | $73.84M 10-Q · filed 2024-02-13 | $118.07M derived: sum of 3 quarters · filed 2024-02-13 | $153.05M derived: sum of 4 quarters · filed 2024-02-13 | |
| 2022-09-30 | $37.76M 10-Q · filed 2023-11-09 | $81.99M derived: sum of 2 quarters · filed 2023-11-09 | $116.97M derived: sum of 3 quarters · filed 2023-11-09 | $148.15M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $44.24M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-21 | $79.22M derived: sum of 2 quarters · filed 2023-09-21 | $110.40M derived: sum of 3 quarters · filed 2023-09-21 | $140.46M 10-K · filed 2023-09-21 | |
| 2022-03-31 | $34.98M 10-Q · filed 2023-05-15 | $66.16M derived: sum of 2 quarters · filed 2023-05-15 | $96.22M 10-Q · filed 2023-05-15 | $132.68M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $31.18M 10-Q · filed 2023-02-08 | $61.24M 10-Q · filed 2023-02-08 | $97.70M derived: sum of 3 quarters · filed 2023-02-08 | $137.19M derived: sum of 4 quarters · filed 2023-02-08 | |
| 2021-09-30 | $30.06M 10-Q · filed 2022-11-09 | $66.52M derived: sum of 2 quarters · filed 2022-11-09 | $106.01M derived: sum of 3 quarters · filed 2022-11-09 | $144.42M derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | $36.46M derived: 10-K 12 month − 10-Q 9 month · filed 2022-09-21 | $75.95M derived: sum of 2 quarters · filed 2022-09-21 | $114.36M derived: sum of 3 quarters · filed 2022-09-21 | $148.08M 10-K · filed 2022-09-21 | |
| 2021-03-31 | $39.48M 10-Q · filed 2022-05-13 | $77.89M derived: sum of 2 quarters · filed 2022-05-13 | $111.61M 10-Q · filed 2022-05-13 | $140.18M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $38.41M 10-Q · filed 2022-02-09 | $72.13M 10-Q · filed 2022-02-09 | $100.69M derived: sum of 3 quarters · filed 2022-02-09 | $123.28M derived: sum of 4 quarters · filed 2022-02-09 | |
| 2020-09-30 | $33.72M 10-Q · filed 2021-11-09 | $62.28M derived: sum of 2 quarters · filed 2021-11-09 | $84.87M derived: sum of 3 quarters · filed 2021-11-09 | $108.92M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $28.56M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-20 | $51.15M derived: sum of 2 quarters · filed 2021-09-20 | $75.19M derived: sum of 3 quarters · filed 2021-09-20 | $100.00M 10-K · filed 2021-09-20 | |
| 2020-03-31 | $22.59M 10-Q · filed 2021-05-13 | $46.63M derived: sum of 2 quarters · filed 2021-05-13 | $71.44M 10-Q · filed 2021-05-13 | $98.05M derived: sum of 4 quarters · filed 2021-05-13 | |
| 2019-12-31 | $24.04M 10-Q · filed 2021-02-09 | $48.85M 10-Q · filed 2021-02-09 | $75.46M derived: sum of 3 quarters · filed 2021-02-09 | $104.59M derived: sum of 4 quarters · filed 2021-02-09 | |
| 2019-09-30 | $24.81M 10-Q · filed 2020-11-10 | $51.42M derived: sum of 2 quarters · filed 2020-11-10 | $80.55M derived: sum of 3 quarters · filed 2020-11-10 | $110.16M derived: sum of 4 quarters · filed 2020-11-10 | |
| 2019-06-30 | $26.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-21 | $55.74M derived: sum of 2 quarters · filed 2020-09-21 | $85.35M derived: sum of 3 quarters · filed 2020-09-21 | $114.72M 10-K · filed 2020-09-21 | |
| 2019-03-31 | $29.13M 10-Q · filed 2020-05-14 | $58.73M derived: sum of 2 quarters · filed 2020-05-14 | $88.10M 10-Q · filed 2020-05-14 | $120.70M derived: sum of 4 quarters · filed 2020-05-14 | |
| 2018-12-31 | $29.61M 10-Q · filed 2020-02-11 | $58.98M 10-Q · filed 2020-02-11 | $91.57M derived: sum of 3 quarters · filed 2020-02-11 | $116.68M derived: sum of 4 quarters · filed 2020-02-11 | |
| 2018-09-30 | $29.37M 10-Q · filed 2019-11-14 | $61.96M derived: sum of 2 quarters · filed 2019-11-14 | $87.07M derived: sum of 3 quarters · filed 2019-11-14 | $113.78M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $32.59M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-24 | $57.70M derived: sum of 2 quarters · filed 2019-09-24 | $84.41M derived: sum of 3 quarters · filed 2019-09-24 | $106.12M 10-K · filed 2019-09-24 | |
| 2018-03-31 | $25.11M 10-Q · filed 2019-05-09 | $51.82M derived: sum of 2 quarters · filed 2019-05-09 | $73.52M 10-Q · filed 2019-05-09 | $98.78M derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | $26.71M 10-Q · filed 2019-02-12 | $48.42M 10-Q · filed 2019-02-12 | $73.68M derived: sum of 3 quarters · filed 2019-02-12 | $93.70M derived: sum of 4 quarters · filed 2019-02-12 | |
| 2017-09-30 | $21.70M 10-Q · filed 2018-11-13 | $46.97M derived: sum of 2 quarters · filed 2018-11-13 | $66.98M derived: sum of 3 quarters · filed 2018-11-13 | ||
| 2017-06-30 | $25.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-19 | $45.28M derived: sum of 2 quarters · filed 2018-09-19 | $95.74M 10-K · filed 2018-09-19 | ||
| 2017-03-31 | $20.02M 10-Q · filed 2018-05-14 | $70.48M 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNATECH INC (MTEX) | United States | $0.014B | |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |